TY - JOUR
T1 - The prevalence of pre-diabetes and diabetes in the Kuwaiti adult population in 2014
AU - Alkandari, Abdullah
AU - Longenecker, Joseph C.
AU - Barengo, Noël C.
AU - Alkhatib, Ahmad
AU - Weiderpass, Elisabete
AU - Al-Wotayan, Rihab
AU - Al Duwairi, Qais
AU - Tuomilehto, Jaakko
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Background: Kuwait ranks among the top 20 countries worldwide in diabetes prevalence. This study's objectives were to assess the prevalence of pre-diabetes and diabetes in Kuwaiti adults. Methods: Kuwaiti citizens aged 18–69 years (n = 3915) were studied using the WHO's STEPwise survey methodology, including its Instrument for Chronic Disease Risk Factor Surveillance. Participants’ demographics, medical history, physical measurements and blood biochemistry were assessed. A subset of 2561 individuals completed all three survey steps, including fasting plasma glucose (FPG) and HbA1c assays. The study assessed the prevalence of pre-diabetes (FPG 6.1–6.9 mmol/L or HbA1c level 5.7–6.4%) and diabetes (self-reported history of diabetes with prescription of diabetes medications or FPG ≥ 7 mmol/L or HbA1c level ≥6.5%). Results: The prevalence of pre-diabetes was 19.4% [95% CI: 17.9–21.0%] (By sex: Men, 19.3%; Women, 19.5%; p = 0.92; By age (years): 18–29 y, 13.9%; 30–44 y, 22.6%; 45–59 y, 25.8%; 60–69 y, 16.4%; p < 0.001). The prevalence of diabetes was 18.8% [17.3–20.4%] (By sex: Men, 20.4%; Women, 17.4%; p = 0.055; By age: 18–29 y, 6.6%; 30–44 y, 14.0%; 45–59 y, 36.7%; 60–69 y, 62.8%; p < 0.001), of whom 41.5% were previously undiagnosed. Diabetes prevalence was 27.4% among those with body mass index (BMI) ≥ 30 kg/m2, 29% among those with elevated waist-hip ratio and 36% among those with hypertension. Diabetes was positively associated with BMI, waist-hip ratio and blood pressure level. Pre-diabetes was positively associated with BMI and waist-hip ratio, but not blood pressure level. Conclusions: Almost 40% of Kuwaiti citizens had pre-diabetes or diabetes. Urgent public health action is needed to decrease diabetes prevalence and thus avoid associated morbidity and mortality.
AB - Background: Kuwait ranks among the top 20 countries worldwide in diabetes prevalence. This study's objectives were to assess the prevalence of pre-diabetes and diabetes in Kuwaiti adults. Methods: Kuwaiti citizens aged 18–69 years (n = 3915) were studied using the WHO's STEPwise survey methodology, including its Instrument for Chronic Disease Risk Factor Surveillance. Participants’ demographics, medical history, physical measurements and blood biochemistry were assessed. A subset of 2561 individuals completed all three survey steps, including fasting plasma glucose (FPG) and HbA1c assays. The study assessed the prevalence of pre-diabetes (FPG 6.1–6.9 mmol/L or HbA1c level 5.7–6.4%) and diabetes (self-reported history of diabetes with prescription of diabetes medications or FPG ≥ 7 mmol/L or HbA1c level ≥6.5%). Results: The prevalence of pre-diabetes was 19.4% [95% CI: 17.9–21.0%] (By sex: Men, 19.3%; Women, 19.5%; p = 0.92; By age (years): 18–29 y, 13.9%; 30–44 y, 22.6%; 45–59 y, 25.8%; 60–69 y, 16.4%; p < 0.001). The prevalence of diabetes was 18.8% [17.3–20.4%] (By sex: Men, 20.4%; Women, 17.4%; p = 0.055; By age: 18–29 y, 6.6%; 30–44 y, 14.0%; 45–59 y, 36.7%; 60–69 y, 62.8%; p < 0.001), of whom 41.5% were previously undiagnosed. Diabetes prevalence was 27.4% among those with body mass index (BMI) ≥ 30 kg/m2, 29% among those with elevated waist-hip ratio and 36% among those with hypertension. Diabetes was positively associated with BMI, waist-hip ratio and blood pressure level. Pre-diabetes was positively associated with BMI and waist-hip ratio, but not blood pressure level. Conclusions: Almost 40% of Kuwaiti citizens had pre-diabetes or diabetes. Urgent public health action is needed to decrease diabetes prevalence and thus avoid associated morbidity and mortality.
KW - Adult
KW - Arab
KW - Pre-diabetes
KW - Prevalence
KW - Public health epidemiology
UR - http://www.scopus.com/inward/record.url?scp=85053378509&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2018.08.016
DO - 10.1016/j.diabres.2018.08.016
M3 - Article
C2 - 30179683
AN - SCOPUS:85053378509
VL - 144
SP - 213
EP - 223
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
SN - 0168-8227
ER -